Open Access 22.06.2020 | COVID-19 | Letter
Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial
Erschienen in: Trials | Ausgabe 1/2020